The purpose of this study was to identify the factors associated with neonatal sepsis among neonates admitted in Kibungo Referral Hospital, Ngoma District, Rwanda. The study findings show that neonatal sepsis prevalence was 12.8%, 29.6% of neonates who experienced sepsis died. Decreasing deaths for newborns and mothers is a global priority to achieve Sustainable Development Goals, and to implement United Nations Global Strategy for Women, Children and Adolescent health.[5] Though Rwanda is among the few countries in Africa which achieved fourth Millennium Development Goal to reduce child mortality, mortality rate among neonates is still of great concern. Neonatal sepsis is still a leading cause of neonatal morbidity and mortality in Rwanda, including the study area.44,45
The prevalence of 12.8% of neonatal sepsis found in this study is less than what was reported by studies from Sudan (37.8%), Tanzania (24%) and Nigeria (47.2%).[15,16,47] However, the prevalence in this study is comparable to the results reported in North Sinai, Cairo (12.8%), but higher than the results reported from South Sinai (8.6%) and Cairo (4.47%).34 The difference in neonatal sepsis prevalence could be attributed to the difference in the study setting in terms of infection prevention and control, staffing, funding, and policy.
The study found that among the 54 with neonatal sepsis, early-onset neonatal sepsis was 57.4% and late-onset 42.6%, which was consistent with the study conducted in South Sinai that found the mothers and hospitals to be the main source of early-onset and late-onset of neonatal sepsis. 34 Early onset neonatal sepsis was a little higher (57.4%) than late onset neonatal sepsis (42.6%) in this study and comparable to a study done in South Sinai where early-onset sepsis stood at 68.2% and late-onset sepsis (31.8%).34 On the other hand, our study results contrasts with what was reported in a research conducted at Mansoura Hospital in Egypt, where early onset sepsis was lower at 44.2% and late onset sepsis was higher 55.8%.46 This could be due to the differences in the different characteristics of mothers and the setting where the study was conducted.
The sepsis fatality rate was 29.6%, which is high and reflects inadequate management of sepsis, perhaps linked to delays in diagnosis and treatment. This sepsis fatality rate is almost similar to the findings of the study done in Tehran (27.4%) and South Sinai 25%. 34,47 Blood cultures were not routinely performed to suspected cases, thus only 25 were collected among the 54 with sepsis, while the rest of neonatal sepsis cases were empirically confirmed. This could be due to the fact that microbiology results took much longer time, triggering the physicians to opt for empirical therapy. Among the 25 blood cultures done, 84% (21/25) were positive with predominance of Klebsiella pneumoniae (62%). The study finding agreed with research done in India, which found preponderance of Klebsiella pneumoniae among neonates.48 Bacteria sensitivity pattern revealed that Klebsiella pneumoniae (46.1%) was resistant to ciprofloxacin and 100% sensitive to meropenem and imipenem in the carbapenem family of medications. The findings of current study are different from a study done in Sudan that reported susceptibility of Klebsiella pneumoniae of 87% to Ciprofloxacin, and 81% to meropenem, which was caused by a variation of antimicrobial susceptibility patterns in bacteria.49
Multivariable analysis revealed that gestational weeks, and neonatal age (days) were statistically significantly associated with neonatal sepsis. Neonates aged 3 days or less were more likely to develop sepsis, (AOR=2.769, CI, 95%; P = 0.008) which is comparable with the study done in Ethiopia neonates with 3 days old or less (AOR = 2.802; CI, 95%, = 0.018) were more likely to develop sepsis.50,51 Prolonged rupture of membrane, place of delivery, health center delivery, intrapartum fever, APGAR Score <7, low birth weight, abnormal amniotic fluid and assisted ventilation were not found as associated factors, in contrast to the studies done in Mexico and Ethiopia which were conducted in urban settings.17,52
In this study information from the laboratory showed the presence of Enterobacter cloacae, Klebsiella pneumoniae, Serratia species, Providencia stuartii and Escherichia coli in the neonatal and maternity wards. The study done in Morocco, Brazil, Austria and India on neonatology environment reported the presence of different bacteria including Klebsiella pneumoniae, coagulase-negative staphylococci and other Enterobacteriaceae. 31,53–55 The presence of those bacteria isolates in the neonatal and maternity settings highlights the need to regularly monitor their environment and execute infection control by improving hygiene and sanitation.
Limitation of the study
The current study did not assess adequately the environmental factors due to the fact that environmental monitoring was not regularly conducted. Inconsistent selection of antibiotics for antibiotic sensitivity did not allow a more robust assessment of blood sensitivity patterns.